These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 20041160

  • 1. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
    Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR.
    PLoS One; 2009 Dec 24; 4(12):e8445. PubMed ID: 20041160
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
    Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J.
    Mol Cancer; 2010 Apr 30; 9():96. PubMed ID: 20433742
    [Abstract] [Full Text] [Related]

  • 3. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.
    Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J.
    Clin Cancer Res; 2008 Dec 15; 14(24):8080-6. PubMed ID: 19088023
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J.
    Mol Med; 2013 Feb 08; 18(1):1491-8. PubMed ID: 23255074
    [Abstract] [Full Text] [Related]

  • 5. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C, Liu J, Tan C, Yue X, Zhao Y, Peng J, Wang X, Laddha SV, Chan CS, Zheng S, Hu W, Feng Z.
    Oncotarget; 2016 Feb 23; 7(8):8783-96. PubMed ID: 26840028
    [Abstract] [Full Text] [Related]

  • 6. Post-transcriptional regulation of the tumor suppressor p53 by a novel miR-27a, with implications during hypoxia and tumorigenesis.
    Maqbool R, Lone SN, Ul Hussain M.
    Biochem J; 2016 Oct 15; 473(20):3597-3610. PubMed ID: 27531966
    [Abstract] [Full Text] [Related]

  • 7. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qi X, Zhao XT, Jin YX.
    Oncol Rep; 2013 Jul 15; 30(1):492-8. PubMed ID: 23670238
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
    Afanasyeva EA, Mestdagh P, Kumps C, Vandesompele J, Ehemann V, Theissen J, Fischer M, Zapatka M, Brors B, Savelyeva L, Sagulenko V, Speleman F, Schwab M, Westermann F.
    Cell Death Differ; 2011 Jun 15; 18(6):974-84. PubMed ID: 21233845
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X, Wang J, Wei L, Peng Q, Gao Y, Fu Y, Lu Y, Qin Z, Zhang X, Lu J, Ou C, Li Z, Zhang X, Liu P, Xiong W, Li G, Yan Q, Ma J.
    J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30209170
    [Abstract] [Full Text] [Related]

  • 10. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.
    Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR.
    Proc Natl Acad Sci U S A; 2007 Aug 14; 104(33):13513-8. PubMed ID: 17686970
    [Abstract] [Full Text] [Related]

  • 11. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F, Marzano F, Valletti A, Aiello I, Di Tullio G, Morgano A, Liuni S, Ranieri E, Guerrini L, Gasparre G, Sbisà E, Pesole G, Moschetta A, Caratozzolo MF, Tullo A.
    Mol Cancer; 2017 Mar 21; 16(1):67. PubMed ID: 28327152
    [Abstract] [Full Text] [Related]

  • 12. miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.
    Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E, Garcia-Foncillas J, Bandres E.
    Mol Cancer Ther; 2010 Aug 21; 9(8):2265-75. PubMed ID: 20647341
    [Abstract] [Full Text] [Related]

  • 13. A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance.
    Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C, Zhou J.
    PLoS One; 2011 Aug 21; 6(12):e29043. PubMed ID: 22194984
    [Abstract] [Full Text] [Related]

  • 14. miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells.
    He J, Feng X, Hua J, Wei L, Lu Z, Wei W, Cai H, Wang B, Shi W, Ding N, Li H, Zhang Y, Wang J.
    Cell Cycle; 2017 Oct 18; 16(20):1943-1953. PubMed ID: 28895780
    [Abstract] [Full Text] [Related]

  • 15. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M, Fukami T, Gotoh S, Nakajima M.
    J Biol Chem; 2017 Mar 24; 292(12):4873-4884. PubMed ID: 28188287
    [Abstract] [Full Text] [Related]

  • 16. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
    Cao JX, Lu Y, Qi JJ, An GS, Mao ZB, Jia HT, Li SY, Ni JH.
    Cell Death Dis; 2014 Sep 25; 5(9):e1426. PubMed ID: 25255219
    [Abstract] [Full Text] [Related]

  • 17. P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
    Laudato S, Patil N, Abba ML, Leupold JH, Benner A, Gaiser T, Marx A, Allgayer H.
    Int J Cancer; 2017 Nov 01; 141(9):1879-1890. PubMed ID: 28656629
    [Abstract] [Full Text] [Related]

  • 18. Tumor suppressor functions of miR-133a in colorectal cancer.
    Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, Ng SS, Yu J.
    Mol Cancer Res; 2013 Sep 01; 11(9):1051-60. PubMed ID: 23723074
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
    Li J, Smith AR, Marquez RT, Li J, Li K, Lan L, Wu X, Zhao L, Ren F, Wang Y, Wang Y, Jia B, Xu L, Chang Z.
    Mol Carcinog; 2018 Oct 01; 57(10):1408-1420. PubMed ID: 29938829
    [Abstract] [Full Text] [Related]

  • 20. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
    Chen Y, Kuang D, Zhao X, Chen D, Wang X, Yang Q, Wan J, Zhu Y, Wang Y, Zhang S, Wang Y, Tang Q, Masuzawa M, Wang G, Duan Y.
    Oncotarget; 2016 Sep 06; 7(36):58148-58161. PubMed ID: 27531900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.